ClotCare: Blood Clots, Stroke, Heart Attack
Monday, October 7, 2024
Home   |   DVT/PE   |   Blood Clots   |   Coumadin/Warfarin   |   New Patients   |   Self Testing   |   Email List   |   Donate

Pick a Topic:

Find info on a:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.

ClotCare is a member of the Coalition to Prevent Deep Vein Thrombosis (DVT Coalition)  ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

New Supplement Devoted to Unfractionated Heparin

Henry I. Bussey, Pharm.D.
August 2004

This supplement to the journal, Pharmacotherapy (Vol 24, Issue 8, Part 2, August, 2004), addresses currently recognized problems of dosing and monitoring unfractionated heparin (UFH) and the use of UFH for prophylaxis in medical patients, for treatment of venous thrombosis, and for treatment of acute coronary syndromes. Pharmacoeconomic and nursing considerations also are addressed.

With the permission of Pharmacotherapy, we have made each article from the supplement available in pdf format. Click on an article's title to view the pdf.

The Inevitability of Change
Authors: Gordon J. Vanscoy, Pharm.D., M.B.A.

Heparin Overview and Issues
Authors: Henry Bussey, Pharm.D., FCCP, FAHA, John L. Francis, Ph.D. and The Heparin Consensus Group

Challenges in Variation and Responsiveness of Unfractionated Heparin
Authors: John L. Francis, Ph.D., James B. Groce III, Pharm.D. and The Heparin Consensus Group

Anticoagulant Prophylaxis in Medical Patients: An Objective Assessment
Authors: Steven Deitelzweig, M.D., FACP, James B. Groce III, Pharm.D. and The Heparin Consensus Group

Treatment of Venous Thromboembolism: Challenging the Unfractionated Heparin Standard
Authors: Edith Nutescu, Pharm.D., Manider Singh-Khalsa, M.D., M.B.A. and The Heparin Consensus Group

Unfractionated Heparin in Cardiology: Redefining the Standard of Practice
Authors: Thomas L. Rihn, Pharm.D., José Díez, M.D., FACC, FSCAI and The Heparin Consensus Group

Unfractionated Heparin Dosing Nomograms: Road Maps to Where?
Authors: Paul P. Dobesh, Pharm.D. and The Heparin Consensus Group

Unfractionated Heparin: Focus on a High-Alert Drug
Authors: Cynthia S. Niccolai, Pharm.D., Rodney W. Hicks, R.N., M.S., M.P.A., Lynn Oertel, M.S., A.P.N., John L. Francis, Ph.D. and The Heparin Consensus Group

Unfractionated Heparin: A Nursing Dilemma
Authors: Lynn B. Oertel, M.S., A.P.N. and The Heparin Consensus Group

Economics of Unfractionated Heparin: Beyond Acquisition Cost
Authors: Paul P. Dobesh, Pharm.D. and The Heparin Consensus Group

Ask a question about blood clots or anticoagulant medications Have questions? Ask ClotCare. Send questions by email to webmaster@clotcare.org.

ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.

Blood Clot Activities Calendar

New Postings:

Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2018 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-860-0487
Send comments to webmaster@clotcare.org.
Monday, October 7, 2024